Insight

Dec 26, 2024, 14:23

Study exploring the role of the lncRNA NEAT1 as an attractive therapeutic candidate in multiple myeloma

Haematologica shared a post on X:

“Long non-coding RNA (lncRNA) have emerged as key players in the regulation of various biological processes.

A new study explores the role of the lncRNA NEAT1 as an attractive therapeutic candidate in multiple myeloma.”

lncRNA

Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma

Authors: Noemi Puccio, Gloria Manzotti, Elisabetta Mereu, Federica Torricelli, Domenica Ronchetti, Michela Cumerlato, Ilaria Craparotta, Laura Di Rito, Marco Bolis, Valentina Traini, Veronica Manicardi, Valentina Fragliasso, Yvan Torrente, Nicola Amodio, Niccolò Bolli, Elisa Taiana, Alessia Ciarrocchi, Roberto Piva, Antonino Neri

lncRNA

Alessia Ciarrocchi Antonino Neri biological processes cancer Domenica Ronchetti Elisa Taiana Elisabetta Mereu Federica Torricelli Gloria Manzotti Haematologica Ilaria Craparotta Laura Di Rito lncRNA Marco Bolis Michela Cumerlato multiple myeloma Niccolò Bolli Nicola Amodio Noemi Puccio OncoDaily Oncology Roberto Piva Valentina Fragliasso Valentina Traini Veronica Manicardi Yvan Torrente

Highlights from TTLC2025

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

New Paper Alert: Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer